Progyny Inc [PGNY] stock is trading at $23.06, up 5.88%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PGNY shares have lost -1.83% over the last week, with a monthly amount drifted -0.77%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Progyny Inc [NASDAQ: PGNY] stock has seen the most recent analyst activity on July 08, 2025, when Leerink Partners upgraded its rating to a Outperform but kept the price target unchanged to $28 for it. Previously, JP Morgan downgraded its rating to Neutral on December 02, 2024, and kept the price target unchanged to $17. On November 13, 2024, downgrade downgraded it’s rating to Hold and revised its price target to $19 on the stock. JMP Securities downgraded its rating to a Mkt Perform. Leerink Partners downgraded its rating to a Market Perform and reduced its price target to $25 on August 07, 2024. Canaccord Genuity downgraded its rating to Hold for this stock on August 07, 2024, and downed its price target to $24. In a note dated August 07, 2024, BTIG Research downgraded a Neutral rating on this stock.
Progyny Inc [PGNY] stock has fluctuated between $13.39 and $26.76 over the past year. Currently, Wall Street analysts expect the stock to reach $26 within the next 12 months. Progyny Inc [NASDAQ: PGNY] shares were valued at $23.06 at the most recent close of the market. An investor can expect a potential return of 12.75% based on the average PGNY price forecast.
Analyzing the PGNY fundamentals
Progyny Inc [NASDAQ:PGNY] reported sales of 1.24B for the trailing twelve months, which represents a growth of 9.47%. Gross Profit Margin for this corporation currently stands at 0.22% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.04%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.12 and Total Capital is 0.14. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 22.11 points at the first support level, and at 21.17 for the second support level. However, for the 1st resistance point, the stock is sitting at 23.60, and for the 2nd resistance point, it is at 24.15.
Ratios To Look Out For
For context, Progyny Inc’s Current Ratio is 2.70. As well, the Quick Ratio is 2.70, while the Cash Ratio is 0.6. Considering the valuation of this stock, the price to sales ratio is 1.60, the price to book ratio is 3.85 and price to earnings (TTM) ratio is 39.15.
Transactions by insiders
Recent insider trading involved GORDON KEVIN K, Director, that happened on Aug 11 ’25 when 2500.0 shares were sold. Director, GORDON KEVIN K completed a deal on Aug 11 ’25 to buy 2500.0 shares. Meanwhile, Director Scott Cheryl sold 2675.0 shares on Jun 11 ’25.
